Lymphedema Sensor Technology Development Study
Validation of Wearable Sensors to Monitor Tissue Hydration and Stiffness in Patients With Lymphedema
1 other identifier
observational
30
1 country
1
Brief Summary
The goal of this clinical trial in adult patients diagnosed with upper extremity lymphedema is to test the safety and effectiveness of small, wearable sensors that may be able to measure lymphedema. The main questions this study aims to answer are:
- Do these sensors detect lymphedema?
- If so, how accurate are these wearable sensors? Participants will complete one in-person measurement session and one phone call with study staff 14 days after the measurement session to check-in on the participant's well-being.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Jan 2025
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 2, 2025
CompletedFirst Posted
Study publicly available on registry
January 16, 2025
CompletedStudy Start
First participant enrolled
January 27, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 3, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 14, 2025
CompletedDecember 30, 2025
December 1, 2025
10 months
January 2, 2025
December 22, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Tissue Hydration Score Recorded from the Tissue Hydration Sensor
This score will determine whether or not fluid associated with lymphedema is detected when compared to previously validated measures (bioimpedance spectroscopy and tissue dielectric constant). This is a continuous ratio level of measurement.
From enrollment to the end of the measurement session (appx. 3 hours)
Tissue Stiffness Score from the Tissue Stiffness Sensor
This score will determine whether or not tissue affected by lymphedema can yield is detected when compared to a comparable clinical measurement device using Young's Modulus. This is a continuous ratio level of measurement.
From enrollment to the end of the measurement session (appx. 3 hours)
Secondary Outcomes (3)
Bioimpedance spectroscopy (BIS) L-Dex score
Three hours
Tissue Dielectric Constant (TDC)
From enrollment to the end of the measurement session (appx. 3 hours)
Volume of the Upper Extremities
Three hours
Study Arms (1)
All Participants
Interventions
All participants will undergo measurement of the upper extremities to test the validity and safety of wearable sensors to measure lymphedema.
Eligibility Criteria
This study will recruit patients using the above specified criteria in the Chicagoland area.
You may qualify if:
- Patients with a diagnosis of unilateral lymphedema that affects the upper extremity (UE).
- Patients previously diagnosed with non-metastatic cancer.
- Adults 18 years of age and older.
You may not qualify if:
- Patients with history of lymphatic surgery.
- Patients with implantable devices (e.g., pacemaker, pacemaker/defibrillator, intrathecal pump, joint replacements, etc.) or any other device deemed unsafe by the treating investigator.
- Patients with an amputation involving the upper extremity.
- Patients with known allergies to adhesives - including silicone adhesives.
- Patients with the following comorbidities: diabetes, congestive heart failure, peripheral vascular disease, irradiated upper extremity skin, psoriasis, atopic dermatitis, open wounds/skin breakdown.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Northwestern Universitylead
- Robert H. Lurie Cancer Centercollaborator
Study Sites (1)
Northwestern University
Chicago, Illinois, 60611, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- CROSS SECTIONAL
- Target Duration
- 2 Weeks
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor at Northwestern University, Department of Physical Therapy and Human Movement Sciences, Director of Cancer Rehabilitation Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Director of Cancer Rehabilitation Stud
Study Record Dates
First Submitted
January 2, 2025
First Posted
January 16, 2025
Study Start
January 27, 2025
Primary Completion
December 3, 2025
Study Completion
December 14, 2025
Last Updated
December 30, 2025
Record last verified: 2025-12